Beilstein J. Org. Chem. 2013, 9, 2354–2357.
Acknowledgements
We thank the CNRS for their financial support. The French
Fluorine Network is also thanked for its support.
References
1. Ojima, I. Fluorine in Medicinal Chemistry and Chemical Biology; Wiley:
2. Dunitz, J. D. ChemBioChem 2004, 5, 614–621.
Figure 2: Reaction of 1a with bis-nucleophiles. (Isolated yields, in
parentheses crude yields determined by 19F NMR with PhOCF3 as an
internal standard).
3. Biffinger, J. C.; Kim, H. W.; DiMagno, S. G. ChemBioChem 2004, 5,
4. Becker, A. Inventory of Industrial Fluoro-biochemicals; Eyrolles: Paris,
1996.
This new method was applied to synthesize a trifluoromethyl-
thio analog (3l) of the well-known tricyclic antidepressant
imipramine (Figure 3). Since the pentafluoroethyl analog 1b of
reagent 1a has also been described previously, a pentafluoro-
ethylthio analog of imipramine was synthesized (4l) (Figure 3).
In the latter case, the obtained yield was lower, certainly due
to the steric hindrance of the CF3CF2S moiety. The pharmaco-
logical properties of these new compounds are under investi-
gation.
5. Jeschke, P. ChemBioChem 2004, 5, 570–589.
6. Müller, K.; Faeh, C.; Diederich, F. Science 2007, 317, 1881–1886.
7. Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V. Chem. Soc. Rev.
8. Hagmann, W. K. J. Med. Chem. 2008, 51, 4359–4369.
9. Bégué, J.-P.; Bonnet-Delpon, D. Bioorganic and Medicinal Chemistry
of Fluorine; John Wiley & Sons, Inc.: Hoboken, 2008.
10.Hansch, C.; Leo, A.; Taft, R. W. Chem. Rev. 1991, 91, 165–195.
11.Langlois, B. R.; Billard, T.; Large, S.; Roques, N. Potentially bioactive
CF3S- and CF3S(O)-substituted compounds. Fluorinated Bioactive
Compounds in the Agricultural & Medical Fields; Chemical & Polymer:
Cheshire, 1999; 24/1–24/8.
12.Szmuszkovicz, J.; Glenn, E. M.; Heinzelman, R. V.; Hester, J. B., Jr.;
Youngdale, G. A. J. Med. Chem. 1966, 9, 527–536.
13.Cherkofsky, S. C. Antiinflammatory
4,5-diaryl-2-(substituted-thio)pyrroles and their corresponding
sulfoxides and sulfones. U.S. Patent US4267184A, May 12, 1981.
14.Davies, P.; Doherty, J. B.; Finke, P. E.; Humes, J. L.; Leudke, E. S.;
Maccoss, M.; Mumford, R. A.; Shah, S. K. Substituted azetidinones
useful in the treatment of leukemia. Brit. Patent GB2266527A, March
11, 1993.
Figure 3: Synthesis of fluoroalkylthio analogs of imipramine. (Isolated
yields, in parentheses crude yields determined by 19F NMR with
PhOCF3 as an internal standard).
15.Dorn, C. P.; Finke, P. E.; Maccoss, M.; Doherty, J. B.; Shah, S. K.;
Hagmann, W. K. Preparation of substituted azetidinones as
anti-inflammatory and antidegenerative agents. Eur. Pat.
EP0481671A1, April 22, 1992.
Conclusion
In conclusion, the trifluoromethanesulfenamide 1a is a very
efficient reagent for the electrophilic trifluoromethylthiolation
which can also react with amines to open a new access to tri-
fluoromethylsulfanylamines. These compounds belong to a new
class of products which may exhibit interesting properties for
further applications – in particular in medicinal chemistry –
owing to the characteristics of the CF3SN moiety.
16.Firestone, R. A.; Barker, P. L.; Pisano, J. M.; Ashe, B. M.;
Dahlgren, M. E. Tetrahedron 1990, 46, 2255–2262.
17.Nakayama, M.; Yamada, M. Sulfonamide derivative-containing
agricultural and horticultural compositions. WO Patent
WO2002054867A1, July 18, 2002.
18.Sahu, K. K.; Ravichandran, V.; Mourya, V. K.; Agrawal, R. K.
19.Schallner, O.; Schwarz, H.-G.; Hoischen, D.; Linker, K.-H.;
Drewes, M. W.; Dahmen, P.; Feucht, D.; Pontzen, R. Preparation of
benzoxazinones and related compounds as herbicides. WO Patent
WO2002006277A1, Jan 24, 2002.
Supporting Information
Supporting Information File 1
Experimental procedure.
20.Tabuchi, T.; Yamamoto, T.; Nakayama, M. Preparation of aryl- or
heterocyclylsulfonamide derivatives as agricultural and horticultural
microbicides. WO Patent WO2000065913A1, Nov 1, 2000.
2356